You have been prescribed:
(to be completed by healthcare professional)
Check the label to make sure that your
InnoLet
®
contains the correct type of
insulin. Take off the pen cap.
Resuspending is easier when the insulin
has reached room temperature.
How to use InnoLet
®
Please see your healthcare professional for any further information about your diabetes treatment.
This sheet is intended as a quick guide only and does not replace InnoLet
®
user manual or the CMI enclosed in your prescribed insulin pack.
InnoLet
®
user manual can be found inside every new pack of InnoLet
®
. The CMI and user manual should be read carefully before use. For distribution by healthcare professionals.
Novo Nordisk Pharmaceuticals Pty Ltd. ABN 40 002 879 996. Level 3, 21 Solent Circuit, Baulkham Hills, NSW 2153. ® Registered trademark of Novo Nordisk A/S. Material No.701906. McK336220. 05/15.
www.novonordisk.com.au
1800 668 626
NovoCare
®
Customer Care Centre
Before every injection:
Check there are at least 12 units
of insulin
left in the cartridge to allow even resuspension.
If there are less than 12 units left, use a new
InnoLet
®
.
Move the pen up and down
between
positions A and B and back so that the glass
ball moves from one end of the cartridge to the
other at least 20 times. Repeat this movement
at least 10 times before each injection. The
movement must always be repeated until the
liquid appears uniformly white and cloudy.
After resuspending the insulin,
complete all of the stages of injection
without delay.
Your InnoLet
®
is designed to work
accurately and safely. It must be handled
with care. Do not refill your InnoLet
®
.
You can clean your InnoLet
®
by wiping
it with a medicinal swab. Do not soak it,
wash or lubricate it. This may damage the
mechanism.
Patients registered with the
National Diabetes Services Scheme
(NDSS) are entitled to 1,200 needles
every 180 day period free of charge
with or without scripts, from NDSS
pharmacies and Diabetes Australia.
Mixtard
®
30/70
biphasic isophane human insulin (rys)
Protaphane
®
isophane human insulin (rys)
4mm 32G
0.23/0.25 x 4mm
6mm 32G Tip
0.23/0.25 x 6mm
8mm 30G
0.3 x 8mm
336220 Novo Nordisk Innolet How To Use Pad v3.indd 2
19/05/15 3:05 PM
You have been prescribed:
(to be completed by healthcare professional)
Check the label to make sure that your
InnoLet
®
contains the correct type of
insulin. Take off the pen cap.
Resuspending is easier when the insulin
has reached room temperature.
How to use InnoLet
®
Please see your healthcare professional for any further information about your diabetes treatment.
This sheet is intended as a quick guide only and does not replace InnoLet
®
user manual or the CMI enclosed in your prescribed insulin pack.
InnoLet
®
user manual can be found inside every new pack of InnoLet
®
. The CMI and user manual should be read carefully before use. For distribution by healthcare professionals.
Novo Nordisk Pharmaceuticals Pty Ltd. ABN 40 002 879 996. Level 3, 21 Solent Circuit, Baulkham Hills, NSW 2153. ® Registered trademark of Novo Nordisk A/S. Material No.701906. McK336220. 05/15.
www.novonordisk.com.au
1800 668 626
NovoCare
®
Customer Care Centre
Before every injection:
Check there are at least 12 units
of insulin
left in the cartridge to allow even resuspension.
If there are less than 12 units left, use a new
InnoLet
®
.
Move the pen up and down
between
positions A and B and back so that the glass
ball moves from one end of the cartridge to the
other at least 20 times. Repeat this movement
at least 10 times before each injection. The
movement must always be repeated until the
liquid appears uniformly white and cloudy.
After resuspending the insulin,
complete all of the stages of injection
without delay.
Your InnoLet
®
is designed to work
accurately and safely. It must be handled
with care. Do not refill your InnoLet
®
.
You can clean your InnoLet
®
by wiping
it with a medicinal swab. Do not soak it,
wash or lubricate it. This may damage the
mechanism.
Patients registered with the
National Diabetes Services Scheme
(NDSS) are entitled to 1,200 needles
every 180 day period free of charge
with or without scripts, from NDSS
pharmacies and Diabetes Australia.
Mixtard
®
30/70
biphasic isophane human insulin (rys)
Protaphane
®
isophane human insulin (rys)
4mm 32G
0.23/0.25 x 4mm
6mm 32G Tip
0.23/0.25 x 6mm
8mm 30G
0.3 x 8mm
336220 Novo Nordisk Innolet How To Use Pad v3.indd 2
19/05/15 3:05 PM
Novo Nordisk Pharmaceuticals Pty Ltd. ABN 40 002 879 996. Level 10, 118 Mount Street, North Sydney, NSW 2060. NovoCare
®
Customer Care Centre (Australia) 1800 668 626
www.novonordisk.com.au ® Registered trademark of Novo Nordisk A/S. AU21NC00003. 709987. Date of preparation: September 2021
